Friday, December 9, 2016

STOP-CA: Testing the effect of statins on cardiac injury after chemotherapy

New Clinical Trials

Dr. Neilan is the PI on a multi-center randomized, placebo-controlled clinical trial testing whether statins prevent the cardiotoxicity after anthracyclines among patients with non-Hodgkin’s Lymphoma (NHL). The primary end-point of the study is the comparison of the left ventricular ejection fraction using cardiac MRI after 12 months of statins or placebo between randomized groups.

Browse the Entire Newsroom Archive

Back to Top